Biotechnology Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in Canada – Scilex Holding (NASDAQ:SCLX) Read more
Biotechnology Scilex Holding Announces Issuance Of Halal Certification For Its ZTlido® Product By Circle H International, Inc. – Scilex Holding (NASDAQ:SCLX) Read more
Biotechnology Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered Into A Definitive Mutual Release And Settlement Agreement With Virpax Pharmaceuticals, Inc. Relating To The Previously Announced Term Sheet With Virpax In Respect Of Such Release And Settlement – Scilex Holding (NASDAQ:SCLX) Read more
Biotechnology Scilex Holding Company Sets Launch Price Of $595 Per 150ml Bottle Of Gloperba®, Its First And Only Liquid Oral Version Of The Anti-Gout Medicine Colchicine Indicated For The Prophylaxis Of Painful Gout Flares In Adults; Expected Plans To Launch In The First Half Of 2024 – Scilex Holding (NASDAQ:SCLX) Read more
Eurozone US Stocks Mixed; Dell Posts Upbeat Results – BioVie (NASDAQ:BIVI), Adial Pharmaceuticals (NASDAQ:ADIL) Read more
Eurozone Nasdaq Surges 100 Points; ISM Manufacturing PMI Falls In February – BioVie (NASDAQ:BIVI), Cardiff Oncology (NASDAQ:CRDF) Read more
Eurozone Crude Oil Rises Over 2%; Fisker Shares Plummet – BioVie (NASDAQ:BIVI), Cardiff Oncology (NASDAQ:CRDF) Read more
Biotechnology Scilex Holding Company Announces $10 Million Bought Deal Offering – Scilex Holding (NASDAQ:SCLX) Read more
Biotechnology Scilex Holding Company Announces Major Initiative With A Leading National Pharmacy Chain To Stock GLOPERBA® In Most Of Their Stores Throughout the U.S. – Scilex Holding (NASDAQ:SCLX) Read more
Biotechnology Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters Into A Term Sheet With Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement Agreement – Scilex Holding (NASDAQ:SCLX) Read more
